These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 35745935)

  • 1. Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy.
    Akulo KA; Adali T; Moyo MTG; Bodamyali T
    Polymers (Basel); 2022 Jun; 14(12):. PubMed ID: 35745935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ formation of injectable chitosan-gelatin hydrogels through double crosslinking for sustained intraocular drug delivery.
    Song Y; Nagai N; Saijo S; Kaji H; Nishizawa M; Abe T
    Mater Sci Eng C Mater Biol Appl; 2018 Jul; 88():1-12. PubMed ID: 29636124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogel Biomaterials for Application in Ocular Drug Delivery.
    Lynch CR; Kondiah PPD; Choonara YE; du Toit LC; Ally N; Pillay V
    Front Bioeng Biotechnol; 2020; 8():228. PubMed ID: 32266248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems.
    Wu KY; Joly-Chevrier M; Akbar D; Tran SD
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
    Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
    Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable hydrogels based on biopolymers for the treatment of ocular diseases.
    Yu C; Xu J; Heidari G; Jiang H; Shi Y; Wu A; Makvandi P; Neisiany RE; Zare EN; Shao M; Hu L
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):132086. PubMed ID: 38705321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy.
    Luo LJ; Nguyen DD; Lai JY
    Biomaterials; 2020 Jun; 243():119961. PubMed ID: 32171102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Methods for the Assessment of a Complex Hydrogel as an Ocular Drug Delivery System for Glaucoma Treatment: Opportunities and Challenges in Preclinical Evaluation.
    Das S; Saha D; Majumdar S; Giri L
    Mol Pharm; 2022 Mar; 19(3):733-748. PubMed ID: 35179892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
    Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.
    Bachu RD; Chowdhury P; Al-Saedi ZHF; Karla PK; Boddu SHS
    Pharmaceutics; 2018 Feb; 10(1):. PubMed ID: 29495528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sericin/Dextran Injectable Hydrogel as an Optically Trackable Drug Delivery System for Malignant Melanoma Treatment.
    Liu J; Qi C; Tao K; Zhang J; Zhang J; Xu L; Jiang X; Zhang Y; Huang L; Li Q; Xie H; Gao J; Shuai X; Wang G; Wang Z; Wang L
    ACS Appl Mater Interfaces; 2016 Mar; 8(10):6411-22. PubMed ID: 26900631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal hydrogels for sustained release of therapeutic proteins.
    Ilochonwu BC; Urtti A; Hennink WE; Vermonden T
    J Control Release; 2020 Oct; 326():419-441. PubMed ID: 32717302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glaucoma: Current treatment and impact of advanced drug delivery systems.
    Yadav KS; Rajpurohit R; Sharma S
    Life Sci; 2019 Mar; 221():362-376. PubMed ID: 30797820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Ocular Delivery System for Glaucoma Therapy Using Natural Hydrogel as Film Forming Agent and Release Modifier.
    Kulkarni GT; Sethi N; Awasthi R; Pawar VK; Pahuja V
    Polim Med; 2016; 46(1):25-33. PubMed ID: 28397416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications.
    Widjaja LK; Bora M; Chan PN; Lipik V; Wong TT; Venkatraman SS
    J Biomed Mater Res A; 2014 Sep; 102(9):3056-65. PubMed ID: 24124098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylation-enhanced biocompatibility of the supramolecular hydrogel of an anti-inflammatory drug for topical suppression of inflammation.
    Xiong T; Li X; Zhou Y; Song Q; Zhang R; Lei L; Li X
    Acta Biomater; 2018 Jun; 73():275-284. PubMed ID: 29660509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Acting Ocular Injectables: Are We Looking In The Right Direction?
    Dang M; Shoichet MS
    Adv Sci (Weinh); 2024 Feb; 11(8):e2306463. PubMed ID: 38018313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-healing DNA-based injectable hydrogels with reversible covalent linkages for controlled drug delivery.
    Basu S; Pacelli S; Paul A
    Acta Biomater; 2020 Mar; 105():159-169. PubMed ID: 31972367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan-Gelatin Hydrogel Crosslinked With Oxidized Sucrose for the Ocular Delivery of Timolol Maleate.
    El-Feky GS; Zayed GM; Elshaier YAMM; Alsharif FM
    J Pharm Sci; 2018 Dec; 107(12):3098-3104. PubMed ID: 30165067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric, injectable, intravitreal hydrogel devices for posterior segment applications and interventions.
    Anwary M; Kumar P; du Toit LC; Choonara YE; Pillay V
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1074-1081. PubMed ID: 29916734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.